Sprucegrove Investment Management Ltd. Purchases 5,400 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Sprucegrove Investment Management Ltd. increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 1.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 409,991 shares of the company’s stock after purchasing an additional 5,400 shares during the quarter. Henry Schein makes up about 1.4% of Sprucegrove Investment Management Ltd.’s portfolio, making the stock its 11th biggest position. Sprucegrove Investment Management Ltd. owned approximately 0.32% of Henry Schein worth $26,280,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Summit Securities Group LLC bought a new position in Henry Schein in the second quarter worth approximately $31,000. Beach Investment Counsel Inc. PA bought a new stake in Henry Schein during the 2nd quarter valued at $37,000. Blue Trust Inc. boosted its position in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares in the last quarter. Mather Group LLC. boosted its position in Henry Schein by 16.8% during the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after acquiring an additional 216 shares in the last quarter. Finally, Palisade Asset Management LLC bought a new stake in Henry Schein during the 1st quarter valued at $113,000. Institutional investors own 96.62% of the company’s stock.

Insider Activity

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Stock Up 0.1 %

Shares of HSIC stock opened at $72.54 on Friday. The stock’s 50-day simple moving average is $69.77 and its 200-day simple moving average is $70.42. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The firm has a market capitalization of $9.29 billion, a PE ratio of 24.51, a P/E/G ratio of 1.88 and a beta of 0.86. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The business had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The company’s revenue was up .0% on a year-over-year basis. During the same period in the prior year, the company earned $1.31 earnings per share. Equities analysts expect that Henry Schein, Inc. will post 4.75 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. UBS Group dropped their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. JPMorgan Chase & Co. dropped their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Robert W. Baird dropped their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Evercore ISI lowered their price objective on Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research report on Wednesday, August 7th. Finally, Barrington Research dropped their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $77.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.